SUMMARY In order to study the relation between intra-and extrahepatocellular alpha1-antitrypsin (a,-AT) 
an acute phase reactant plasma protein with broad spectrum antiprotease activity synthesised by the hepatocytes. A selective increase of its plasma concentration is often seen in liver disease and this level generally seems to reflect the activity of the disease.' Low plasma concentrations are seen in some phenotypes. Ofspecial interest is the PiZphenotype in which increased frequencies of fibrosis, cirrhosis and hepatoma23 have been reported. Neonatal hepatitis occurs in 10 % of homozygous Pi Z children and increased hepatic enzyme activity is found in approximately 50 % of Pi children.4 Typical PASpositive inclusion bodies, first described by Sharp et al.,5 and consisting of aggregated oti-AT lacking sialic acid and with an amino acid substitution6 are seen in Pi Z hepatocytes. Such inclusions were first thought to be pathognomonic for the Z allele7 but several reports during the past few years have disputed this assumption. Heterozygous Pi MZ individuals also have globular inclusions and one case of hepatocellular carcinoma in a 16-year-old MZ boy has been reported,8 but most investigators have found no evidence of increased liver disease frequency in such individuals.
Accepted for publication 7 January 1981 xcx-AT may have an important protective role as a protease inhibitor in liver disease. The mechanisms regulating the plasma concentration in both normal and other phenotypes are, however, incompletely known. To gain insight into these mechanisms we have studied (i) the relation between intrahepatocellular immunoreactive oc1-AT and plasma concentrations in various liver diseases; (ii) the frequency and some clinical conditions associated with globular inclusions (ml-AT globules) in absence of the Z allele and (iii) the distribution of phenotypic groups among patients with liver disease. The study was performed prospectively using an oci-AT-specific immunoperoxidase staining in addition to routine PAS-staining of 250 1-9 ± 0 7 (SD) and 0 2 g/l higher (0 32 > p > 0 10) than for patients with negative biopsies. Mean biopsy score was 7 6 ± 5-1 (SD) compared to 5 * 3 ± 4 * 4 (0 05 > p > 0 * 01). Inflammatory activities were I 4 ± 1 * 0 and 1 0 ± 0 -9 (0* 05 > p > 0.01) for the two groups, respectively. Biopsies from 102 patients showed positive (xi-AT staining in leucocytes, Kupffer's cells or round cells, but no differences were found between mean plasma al-AT concentrations, biopsy scores or activities in these and patients with negative biopsies. The probability that the frequency of the Z gene in liver patients is the same as that among normal Norwegians and Swedes is 0 * 50 > p > 0 * I0
using the x' test. The major contribution to the difference arises in the Z gene group. tM-phenotype deduced in absence of family studies, phenotyping done by starch gel and crossed immunoelectrophoresis. Plasma a,-AT by the Mancini technique, reference 2 1 g/l. $As for ' with reference for P-a,-AT 1 *8-3 g/l. §Plasma a,-AT determined by electroimmunoassay (reference 0 * 9-1 * 70, average value 1 32 g/l), Pi typing by isoelectric focusing. Fig. 1 ) probably had such globules, but they were present periportally as well as centrilobularly and could not with certainty be distinguished from al-AT globules. In this case alone globules stained positively even with antisera for fibrinogen, IgG, and albumin.
It appears from our cases and those presented in Table 3 
